Overview
Hemostasis is a physiological mechanism that keeps blood fluid by preventing it from leaking out of the body. Hemostasis is defined by the activation of the natural coagulation cascade, which results in the production of clots. Major operations and trauma, on the other hand, result in significant blood loss that cannot be halted by the natural healing process. Hemostats and tissue sealing agents can help in such instances by reducing blood loss and speeding up the healing process. Excessive bleeding during surgical operations can put patients at danger, thus hemostats and tissue sealing agents are becoming more popular. Excessive bleeding can also lead to postoperative problems such as longer surgical procedures and the lack of blood in the body. As a result, preventing such events is critical for favorable patient outcomes and surgical operation efficacy.
The global hemostasis and tissue sealing agents market was worth US$ 3,236.2 million in 2017 and is anticipated to grow at an impressive CAGR of 8.1 percent from 2017 to 2025.
Request for Analysis of COVID-19 Impact on Hemostasis & Tissue Sealing Agents Market – https://www.coherentmarketinsights.com/insight/request-sample/1567
Drivers
The global hemostasis and tissue sealing agents market is projected to develop considerably as a result of factors such as an increase in the number of surgical operations and a rise in the number of traffic accidents. According to the Health and Social Care Information Centre (HSCIC), surgery is one of the most common treatments provided by the NHS in the U.K., accounting for 4.7 million admissions across a range of locations. The data also shows that between 2004 and 2014, the number of surgical operations grew by 27%. According to the Centers for Disease Control and Prevention (CDC), about 200,000 people died in the United States in 2014 as a result of trauma injuries. An increase in the number of traffic accidents has resulted in severe sports injuries, which is a key element driving demand for the global hemostats and tissue sealing agents market. According to the World Health Organization, more than half of those injured in car accidents were brought to hospitals and had trauma surgery in 2016.
Restraints
The global hemostasis and tissue sealing agents market development is projected to be hampered by the lack of favorable reimbursement policies for hemostat failure in blood loss management, as well as rising surgical treatment costs.
Regional Analysis
Due to the inclusion of updated technology in new products and intensive research and development, North America is expected to lead the global hemostasis and tissue sealing agents market.
This is due to leading market participants in the region rapidly developing and launching innovative tissue sealing chemicals and solutions. StablePlate RX Canine was released in March 2018 by BodeVet, Inc., a blood-related solutions firm, as the world’s first injectable freeze-dried platelet derived product for the management of pain uncontrolled hemorrhage in cardiac patients.
Due to expanding surgical operations as a result of increased medical tourism in emerging nations like China, Singapore, and India, Asia Pacific is anticipated to rise rapidly throughout the forecast period. The growing frequency of traffic accidents in the Asia Pacific region, which leads to trauma admissions in emergency rooms, is also expected to drive market development in the area during the forecast period. According to the Ministry of Road Transport and Highways of the Indian government, 500,279 people were wounded in road accidents in 2015. These aspects are projected to help the market expand.
Request PDF Brochure Report –
https://www.coherentmarketinsights.com/insight/request-pdf/1567
Competitive Landscape
Major market participants are focusing on expanding their footprint in emerging markets by launching new product lines. Baxter International, Inc. finalized the acquisition of two hemostat products from Mallinckrodt in March 2018, and announced the introduction of RECOTHORM and PREVELEAK hemostat sealants in Japan to expand its client base. In order to increase their market share, businesses are also focused on developing novel goods. SURGICEL powdered absorbable hemostat was released in January 2018 by Ethicon LLC, a division of Johnson & Johnson Medical Devices Companies, to help control disruptive bleeding on wide and leaking surfaces.
Major companies contributing in the global hemostasis & tissue sealing agents market are Integra Lifesciences Corporation, Dickinson & Company, Pfizer, Inc., Ethicon LLC, Baxter International, Inc., MIL Laboratories Pvt. Ltd, Cryolife, Inc. Advanced Medical Solutions Group Plc., B. Braun Melsungen AG, Medtronic plc., Cohera Medical, Inc., and Becton.
Detailed Segmentation:
By Product Type:
-
- Topical Hemostats
- Mechanical Hemostats
- Collagen Based Hemostats
- Cellulose Based Hemostats
- Gelatin Based Hemostats
- Polysaccharide Based Hemostats
- Active Hemostats
- Flowable Hemostats
- Mechanical Hemostats
- Adhesives & Tissue Sealing Agents
- Natural Tissue Sealants
- Synthetic Tissue Sealants
- Adhesion Barrier Products
- Topical Hemostats
By End User:
-
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
Reasons to Purchase this Report
Current and future of global Hemostasis & Tissue Sealing Agents market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1567
Major Point Answered in Hemostasis & Tissue Sealing Agents Market Research Study are:
What will be the progress rate of the Hemostasis & Tissue Sealing Agents Market for the conjecture period, 2020-2027?
What are the prominent factors driving the Hemostasis & Tissue Sealing Agents Market across different regions?
Who are the major vendors dominating the Hemostasis & Tissue Sealing Agents industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the Hemostasis & Tissue Sealing Agents Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837